Emerging at the UK, retatrutide, a novel compound , is creating considerable excitement within the scientific community regarding its potential for physique management . This dual GIP and GLP-1 agent agonist appears to offer a considerable improvement over established therapies, showing encouraging results in early clinical trials . Researchers thi